On Invalid Date, Tff Pharmaceuticals (NASDAQ: TFFP) reported Q3 2023 earnings per share (EPS) of -$2.25, up 68.97% year over year. Total Tff Pharmaceuticals earnings for the quarter were -$4.41 million. In the same quarter last year, Tff Pharmaceuticals's earnings per share (EPS) was -$7.25.
As of Q1 2024, Tff Pharmaceuticals's earnings has grown year over year. Tff Pharmaceuticals's earnings in the past year totalled -$23.85 million.
What is TFFP's earnings date?
Tff Pharmaceuticals's earnings date is Invalid Date. Add TFFP to your watchlist to be reminded of TFFP's next earnings announcement.
What was TFFP's revenue last quarter?
On Invalid Date, Tff Pharmaceuticals (NASDAQ: TFFP) reported Q3 2023 revenue of $234.76 thousand up 168.04% year over year. In the same quarter last year, Tff Pharmaceuticals's revenue was $87.59 thousand.
What was TFFP's revenue growth in the past year?
As of Q1 2024, Tff Pharmaceuticals's revenue has grown 378.06% year over year. This is 208.76 percentage points higher than the US Biotechnology industry revenue growth rate of 169.3%. Tff Pharmaceuticals's revenue in the past year totalled $932.32 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.